State of Wisconsin Investment Board
ACAD icon

State of Wisconsin Investment Board’s Acadia Pharmaceuticals ACAD Stock Holding History

State of Wisconsin Investment Board’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.48M Buy
156,422
+6,036
+4% +$144K 0.01% 1137
2025
Q4 		$4.02M Sell
150,386
-38,811
-21% -$927K 0.01% 1090
2025
Q3 		$4.04M Buy
189,197
+2,836
+2% +$67.1K 0.01% 1037
2025
Q2 		$4.02M Sell
186,361
-6,243
-3% -$116K 0.01% 1006
2025
Q1 		$3.2M Sell
192,604
-46,140
-19% -$838K 0.01% 1081
2024
Q4 		$4.38M Buy
238,744
+190
+0.1% +$3.07K 0.01% 1003
2024
Q3 		$3.67M Sell
238,554
-4,080
-2% -$68.1K 0.01% 1073
2024
Q2 		$3.94M Buy
242,634
+48,680
+25% +$786K 0.01% 1026
2024
Q1 		$3.59M Buy
193,954
+65,528
+51% +$1.62M 0.01% 1066
2023
Q4 		$4.02M Buy
128,426
+21,841
+20% +$522K 0.01% 1056
2023
Q3 		$2.22M Buy
106,585
+853
+0.8% +$23.2K 0.01% 1224
2023
Q2 		$2.53M Sell
105,732
-13,028
-11% -$290K 0.01% 1230
2023
Q1 		$2.24M Sell
118,760
-3,076
-3% -$58.6K 0.01% 1267
2022
Q4 		$1.94M Sell
121,836
-1,532
-1% -$23.9K 0.01% 1326
2022
Q3 		$2.02M Sell
123,368
-6,263
-5% -$101K 0.01% 1342
2022
Q2 		$1.83M Sell
129,631
-30,669
-19% -$572K ﹤0.01% 1393
2022
Q1 		$3.88M Hold
160,300
– – 0.01% 1260
2021
Q4 		$3.74M Buy
160,300
+5,200
+3% +$105K 0.01% 1120
2021
Q3 		$2.58M Hold
155,100
– – 0.01% 1227
2021
Q2 		$3.78M Buy
155,100
+140,877
+990% +$3.18M 0.01% 1130
2021
Q1 		$367K Sell
14,223
-7
-0% -$308 ﹤0.01% 1696
2020
Q4 		$761K Sell
14,230
-600
-4% -$29.8K ﹤0.01% 1407
2020
Q3 		$612K Sell
14,830
-850
-5% -$36.7K ﹤0.01% 1410
2020
Q2 		$760K Sell
15,680
-158,020
-91% -$7.59M ﹤0.01% 1304
2020
Q1 		$7.34M Buy
173,700
+9,200
+6% +$379K 0.02% 623
2019
Q4 		$7.04M Hold
164,500
– – 0.02% 821
2019
Q3 		$5.92M Hold
164,500
– – 0.02% 781
2019
Q2 		$4.4M Buy
164,500
+28,400
+21% +$725K 0.01% 845
2019
Q1 		$3.65M Buy
136,100
+35,000
+35% +$817K 0.01% 885
2018
Q4 		$1.64M Sell
101,100
-800
-0.8% -$15.5K 0.01% 1011
2018
Q3 		$2.12M Hold
101,900
– – 0.01% 1033
2018
Q2 		$1.56M Buy
101,900
+82,221
+418% +$1.47M ﹤0.01% 1038
2018
Q1 		$442K Sell
19,679
-582
-3% -$16.1K ﹤0.01% 1324
2017
Q4 		$610K Buy
20,261
+606
+3% +$19.4K ﹤0.01% 1257
2017
Q3 		$740K Buy
19,655
+543
+3% +$17.7K ﹤0.01% 1190
2017
Q2 		$533K Sell
19,112
-3,140
-14% -$93.6K ﹤0.01% 1261
2017
Q1 		$765K Sell
22,252
-32,974
-60% -$1.16M ﹤0.01% 1090
2016
Q4 		$1.59M Sell
55,226
-8,914
-14% -$236K 0.01% 1106
2016
Q3 		$2.04M Buy
64,140
+2,100
+3% +$71.2K 0.01% 1104
2016
Q2 		$2.01M Buy
+62,040
New +$2.08M 0.01% 1082

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State of Wisconsin Investment Board's ACAD Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Acadia Pharmaceuticals (ACAD) stake by 4% in Q1 2026, buying an estimated $144K and bringing the position to 156,422 shares worth $3.48M. The position accounts for 0.01% of the portfolio, ranked #1137.

State of Wisconsin Investment Board first reported a position in ACAD in Q2 2016 and has held it in 40 quarters since. The position peaked at $7.34M in Q1 2020. 342 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • State of Wisconsin Investment Board held 156,422 shares of Acadia Pharmaceuticals worth $3.48M as of Q1 2026.
  • State of Wisconsin Investment Board bought 6,036 Acadia Pharmaceuticals shares in Q1 2026, an estimated $144K.
  • Acadia Pharmaceuticals made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1137 holding.
  • State of Wisconsin Investment Board first reported a position in Acadia Pharmaceuticals in Q2 2016 and has held it in 40 quarters since.
  • State of Wisconsin Investment Board's Acadia Pharmaceuticals position peaked at $7.34M in Q1 2020.
  • 342 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.